Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)

View source ↗

Summary

A clinical trial investigating multimodal artificial intelligence to predict treatment response and refine risk stratification in esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shu Peng | Conditions: Esophageal Cancer | Status: RECRUITING